1. Home
  2. NVO vs CSCO Comparison

NVO vs CSCO Comparison

Compare NVO & CSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • CSCO
  • Stock Information
  • Founded
  • NVO 1923
  • CSCO 1984
  • Country
  • NVO Denmark
  • CSCO United States
  • Employees
  • NVO N/A
  • CSCO 90400
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • CSCO Computer Communications Equipment
  • Sector
  • NVO Health Care
  • CSCO Telecommunications
  • Exchange
  • NVO Nasdaq
  • CSCO Nasdaq
  • Market Cap
  • NVO 278.0B
  • CSCO 273.0B
  • IPO Year
  • NVO N/A
  • CSCO 1990
  • Fundamental
  • Price
  • NVO $68.95
  • CSCO $67.95
  • Analyst Decision
  • NVO Buy
  • CSCO Buy
  • Analyst Count
  • NVO 3
  • CSCO 19
  • Target Price
  • NVO $112.00
  • CSCO $69.59
  • AVG Volume (30 Days)
  • NVO 7.9M
  • CSCO 22.4M
  • Earning Date
  • NVO 08-06-2025
  • CSCO 08-13-2025
  • Dividend Yield
  • NVO 1.71%
  • CSCO 2.41%
  • EPS Growth
  • NVO 17.93
  • CSCO N/A
  • EPS
  • NVO 3.40
  • CSCO 2.45
  • Revenue
  • NVO $43,922,211,349.00
  • CSCO $55,623,000,000.00
  • Revenue This Year
  • NVO $18.59
  • CSCO $7.33
  • Revenue Next Year
  • NVO $15.61
  • CSCO $5.22
  • P/E Ratio
  • NVO $20.26
  • CSCO $27.75
  • Revenue Growth
  • NVO 24.11
  • CSCO 0.47
  • 52 Week Low
  • NVO $57.00
  • CSCO $44.50
  • 52 Week High
  • NVO $143.49
  • CSCO $69.78
  • Technical
  • Relative Strength Index (RSI)
  • NVO 44.58
  • CSCO 56.29
  • Support Level
  • NVO $68.65
  • CSCO $68.31
  • Resistance Level
  • NVO $71.75
  • CSCO $69.39
  • Average True Range (ATR)
  • NVO 1.41
  • CSCO 0.87
  • MACD
  • NVO -0.24
  • CSCO -0.20
  • Stochastic Oscillator
  • NVO 42.59
  • CSCO 48.74

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About CSCO Cisco Systems Inc. (DE)

Cisco Systems is the largest provider of networking equipment in the world and one of the largest software companies in the world. Its largest businesses are selling networking hardware and software (where it has leading market shares) and cybersecurity software such as firewalls. It also has collaboration products, like its Webex suite, and observability tools. It primarily outsources its manufacturing to third parties and has a large sales and marketing staff—25,000 strong across 90 countries. Overall, Cisco employs 80,000 people and sells its products globally.

Share on Social Networks: